Tetrandrine enhances anti-PD-1 immunotherapeutic efficacy for hepatocellular carcinoma by activating STING/TBK1/IRF3 pathway.

Saved in:
Bibliographic Details
Title: Tetrandrine enhances anti-PD-1 immunotherapeutic efficacy for hepatocellular carcinoma by activating STING/TBK1/IRF3 pathway.
Authors: Zheng B; Department of Surgery, The First Dongguan Affiliated Hospital, Guangdong Medical University, Dongguan, Guangdong, China., Yao G; Department of Geriatrics, The First Affiliated Hospital of Shenzhen University, Shenzhen Second People's Hospital, Shenzhen, Guangdong, China., Pang Y; Health Management Center, The First Dongguan Affiliated Hospital, Guangdong Medical University, Dongguan, Guangdong, China., Luo J; Department of Gastrointestinal Surgery, The First Dongguan Affiliated Hospital, Guangdong Medical University, Dongguan, Guangdong, China., Yang Z; Department of Gastrointestinal Surgery, The First Dongguan Affiliated Hospital, Guangdong Medical University, Dongguan, Guangdong, China., Xiu F; Department of Gastrointestinal Surgery, The First Dongguan Affiliated Hospital, Guangdong Medical University, Dongguan, Guangdong, China., Zhen C; Department of Gastrointestinal Surgery, The First Dongguan Affiliated Hospital, Guangdong Medical University, Dongguan, Guangdong, China., Liang R; Department of Gastrointestinal Surgery, The First Dongguan Affiliated Hospital, Guangdong Medical University, Dongguan, Guangdong, China.
Source: Frontiers in immunology [Front Immunol] 2026 Jun 09; Vol. 17, pp. 1850149. Date of Electronic Publication: 2026 Jun 09 (Print Publication: 2026).
Publication Type: Journal Article
Journal Info: Publisher: Frontiers Research Foundation] Country of Publication: Switzerland NLM ID: 101560960 Publication Model: eCollection Cited Medium: Internet ISSN: 1664-3224 (Electronic) Linking ISSN: 16643224 NLM ISO Abbreviation: Front Immunol Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Description
ISSN:1664-3224
DOI:10.3389/fimmu.2026.1850149